BIOTHERYX, INC. — Form D
BIOTHERYX, INC. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-02. The offering totals $100.0M, of which $92.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-06-02
- Form: D
- Accession: 0001788365-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $100.0M
- Amount sold: $92.1M
- Remaining: $7.9M
- Investors: 40
- Date of first sale: 2021-05-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-401380
Issuer
- Name: BIOTHERYX, INC.
- CIK: 0001458857
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Address: 7966 Arjons Dr., Suite D, San Diego, CA, 92126
- Phone: (858) 550-6000
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Louis WH DeGennaro | Director | San Diego, CA |
| Christopher A Devine | Director | San Diego, CA |
| Jack A Noelke | Director | San Diego, CA |
| David I Stirling | Director | San Diego, CA |
| Robert F Williamson | Director | San Diego, CA |
| Kyle WH Chan | Executive Officer | San Diego, CA |
| Jaime A Donadio | Executive Officer | San Diego, CA |
| Frank WH Mercurio | Executive Officer | San Diego, CA |
| David I Stirling | Executive Officer | San Diego, CA |
| Dung WH Thai | Executive Officer | San Diego, CA |
| Robert F Williamson | Executive Officer | San Diego, CA |
| Kyle Chan, PhD | Executive Officer | Chappaqua, NY |
| David Stirling, PhD | Director | Chappaqua, NY |
| David Stirling, PhD | Executive Officer | Chappaqua, NY |
| Louis DeGennaro, PhD | Director | Chappaqua, NY |
| Lawrence Zaslow | Director | Chappaqua, NY |
| Lawrence Zaslow | Executive Officer | Chappaqua, NY |
| Frank Mercurio, PhD | Executive Officer | Chappaqua, NY |
Other filings by this issuer (3)
More